EIF2A and metabolic dysfunction-associated steatohepatitis: In this context, Drp1 knockdown exacerbated the NASH-induced increase in the expression of total eIf2α, p-eIf2α (Figure 5A,B) and its downstream targets Atf3 and Ddit3 (Figure 5C).